BioLineRx and Hemispherian Report Promising GLIX1 Ovarian Cancer Data
TEL AVIV, Israel & OSLO, Norway, July 8, 2026 BioLineRx Ltd. and Hemispherian AS have announced encouraging new preclinical...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
TEL AVIV, Israel & OSLO, Norway, July 8, 2026 BioLineRx Ltd. and Hemispherian AS have announced encouraging new preclinical...
DUBLIN, Ireland, July 8, 2026 Keenova Therapeutics plc has announced positive Phase 3 clinical trial results for XIAFLEX® (collagenase...
